Non-Hodgkin's lymphoma: Present status and future prospects

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Both management and prognosis vary with the many different varieties of non-Hodgkin's lymphoma. In large-cell disease, age and other risk factors influence prognosis. Relapses may respond to chemotherapy plus autologous bone marrow transplantation. Therapy with antibodies to tumor cells has made its debut, but its role remains unclear.

Original languageEnglish (US)
Pages (from-to)81-88
Number of pages8
JournalHospital Practice
Volume34
Issue number13
StatePublished - Dec 15 1999

Fingerprint

Non-Hodgkin's Lymphoma
Neoplasm Antibodies
Autologous Transplantation
Bone Marrow Transplantation
Recurrence
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Non-Hodgkin's lymphoma : Present status and future prospects. / Habermann, Thomas Matthew.

In: Hospital Practice, Vol. 34, No. 13, 15.12.1999, p. 81-88.

Research output: Contribution to journalArticle

@article{ba29a2b093064c329a89cd9b1c2c9070,
title = "Non-Hodgkin's lymphoma: Present status and future prospects",
abstract = "Both management and prognosis vary with the many different varieties of non-Hodgkin's lymphoma. In large-cell disease, age and other risk factors influence prognosis. Relapses may respond to chemotherapy plus autologous bone marrow transplantation. Therapy with antibodies to tumor cells has made its debut, but its role remains unclear.",
author = "Habermann, {Thomas Matthew}",
year = "1999",
month = "12",
day = "15",
language = "English (US)",
volume = "34",
pages = "81--88",
journal = "Hospital practice (1995)",
issn = "2154-8331",
publisher = "Taylor and Francis Ltd.",
number = "13",

}

TY - JOUR

T1 - Non-Hodgkin's lymphoma

T2 - Present status and future prospects

AU - Habermann, Thomas Matthew

PY - 1999/12/15

Y1 - 1999/12/15

N2 - Both management and prognosis vary with the many different varieties of non-Hodgkin's lymphoma. In large-cell disease, age and other risk factors influence prognosis. Relapses may respond to chemotherapy plus autologous bone marrow transplantation. Therapy with antibodies to tumor cells has made its debut, but its role remains unclear.

AB - Both management and prognosis vary with the many different varieties of non-Hodgkin's lymphoma. In large-cell disease, age and other risk factors influence prognosis. Relapses may respond to chemotherapy plus autologous bone marrow transplantation. Therapy with antibodies to tumor cells has made its debut, but its role remains unclear.

UR - http://www.scopus.com/inward/record.url?scp=0033573351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033573351&partnerID=8YFLogxK

M3 - Article

C2 - 10611900

AN - SCOPUS:0033573351

VL - 34

SP - 81

EP - 88

JO - Hospital practice (1995)

JF - Hospital practice (1995)

SN - 2154-8331

IS - 13

ER -